These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 7786196)
1. Cellular and molecular biology of aryl hydrocarbon (Ah) receptor-mediated gene expression. Safe S; Krishnan V Arch Toxicol Suppl; 1995; 17():99-115. PubMed ID: 7786196 [TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells. Krishnan V; Porter W; Santostefano M; Wang X; Safe S Mol Cell Biol; 1995 Dec; 15(12):6710-9. PubMed ID: 8524236 [TBL] [Abstract][Full Text] [Related]
4. Functional and physical interactions between the estrogen receptor Sp1 and nuclear aryl hydrocarbon receptor complexes. Wang F; Hoivik D; Pollenz R; Safe S Nucleic Acids Res; 1998 Jun; 26(12):3044-52. PubMed ID: 9611253 [TBL] [Abstract][Full Text] [Related]
5. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Safe SH Pharmacol Ther; 1995; 67(2):247-81. PubMed ID: 7494865 [TBL] [Abstract][Full Text] [Related]
6. The silencing mediator of retinoic acid and thyroid hormone receptors can interact with the aryl hydrocarbon (Ah) receptor but fails to repress Ah receptor-dependent gene expression. Rushing SR; Denison MS Arch Biochem Biophys; 2002 Jul; 403(2):189-201. PubMed ID: 12139968 [TBL] [Abstract][Full Text] [Related]
7. Identification of 3'-methoxy-4'-nitroflavone as a pure aryl hydrocarbon (Ah) receptor antagonist and evidence for more than one form of the nuclear Ah receptor in MCF-7 human breast cancer cells. Lu YF; Santostefano M; Cunningham BD; Threadgill MD; Safe S Arch Biochem Biophys; 1995 Jan; 316(1):470-7. PubMed ID: 7840652 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional activation of c-fos protooncogene by 17beta-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition. Duan R; Porter W; Samudio I; Vyhlidal C; Kladde M; Safe S Mol Endocrinol; 1999 Sep; 13(9):1511-21. PubMed ID: 10478842 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of aryl hydrocarbon receptor antagonists: inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1A1 gene expression. Merchant M; Morrison V; Santostefano M; Safe S Arch Biochem Biophys; 1992 Nov; 298(2):389-94. PubMed ID: 1329656 [TBL] [Abstract][Full Text] [Related]
10. Interaction of the regulatory domains of the murine Cyp1a1 gene with two DNA-binding proteins in addition to the Ah receptor and the Ah receptor nuclear translocator (ARNT). Carrier F; Chang CY; Duh JL; Nebert DW; Puga A Biochem Pharmacol; 1994 Nov; 48(9):1767-78. PubMed ID: 7980646 [TBL] [Abstract][Full Text] [Related]
11. Failure of Ah receptor to mediate induction of cytochromes P450 in the CYP1 family in the human hepatoma line SK-Hep-1. Roberts EA; Harper PA; Wong JM; Wang Y; Yang S Arch Biochem Biophys; 2000 Dec; 384(1):190-8. PubMed ID: 11147830 [TBL] [Abstract][Full Text] [Related]
12. Role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon (dioxin) receptor action. Probst MR; Reisz-Porszasz S; Agbunag RV; Ong MS; Hankinson O Mol Pharmacol; 1993 Sep; 44(3):511-8. PubMed ID: 8396713 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of estrogen-induced activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the MCF-7 human breast cancer and other cell lines transfected with vitellogenin A2 gene promoter constructs. Nodland KI; Wormke M; Safe S Arch Biochem Biophys; 1997 Feb; 338(1):67-72. PubMed ID: 9015389 [TBL] [Abstract][Full Text] [Related]
14. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces plasminogen activator inhibitor-1 through an aryl hydrocarbon receptor-mediated pathway in mouse hepatoma cell lines. Son DS; Rozman KK Arch Toxicol; 2002 Jul; 76(7):404-13. PubMed ID: 12111005 [TBL] [Abstract][Full Text] [Related]
15. Potentiation of CYP1A1 gene expression in MCF-7 human breast cancer cells cotreated with 2,3,7,8-tetrachlorodibenzo-p-dioxin and 12-O-tetradecanoylphorbol-13-acetate. Moore M; Narasimhan TR; Steinberg MA; Wang X; Safe S Arch Biochem Biophys; 1993 Sep; 305(2):483-8. PubMed ID: 8396892 [TBL] [Abstract][Full Text] [Related]
16. Indolo[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity. Liu H; Wormke M; Safe SH; Bjeldanes LF J Natl Cancer Inst; 1994 Dec; 86(23):1758-65. PubMed ID: 7966413 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of estrogen-induced progesterone receptor in MCF-7 human breast cancer cells by aryl hydrocarbon (Ah) receptor agonists. Harper N; Wang X; Liu H; Safe S Mol Cell Endocrinol; 1994 Aug; 104(1):47-55. PubMed ID: 7821706 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of alpha-naphthoflavone as an Ah receptor antagonist in MCF-7 human breast cancer cells. Merchant M; Krishnan V; Safe S Toxicol Appl Pharmacol; 1993 Jun; 120(2):179-85. PubMed ID: 8390116 [TBL] [Abstract][Full Text] [Related]
19. Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced pS2 expression. Zacharewski TR; Bondy KL; McDonell P; Wu ZF Cancer Res; 1994 May; 54(10):2707-13. PubMed ID: 8168101 [TBL] [Abstract][Full Text] [Related]
20. Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells. Döhr O; Vogel C; Abel J Arch Biochem Biophys; 1995 Aug; 321(2):405-12. PubMed ID: 7646066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]